Newborn And Infant Care - USMLE Step 2

SECTION 1

Historical Context & Motivation

For most of recorded history, newborn mortality was regarded as an unavoidable tragedy, with roughly one in four infants failing to survive their first year. The development of modern neonatal medicine as a distinct subspecialty transformed this picture by systematizing the assessment, resuscitation, and longitudinal care of the newborn. Advances in delivery room practices, screening protocols, and immunization schedules collectively drove the neonatal mortality rate in developed countries below 5 per 1,000 live births by the early twenty-first century. Understanding the evolution of newborn care provides essential context for the clinical standards tested on USMLE Step 2, where clinicians are expected to integrate physiology, pharmacology, and preventive medicine into a unified approach to the first year of life.

1953 • Introduction of the Apgar Score

Virginia Apgar published a rapid five-component scoring system for evaluating newborn vitality at 1 and 5 minutes of life, replacing subjective clinical impression with a standardized numeric assessment.

1963 • Surfactant Therapy Research Begins

Mary Ellen Avery demonstrated that hyaline membrane disease results from surfactant deficiency, paving the way for exogenous surfactant therapy that would later dramatically reduce preterm mortality.

1971 • Universal Newborn Screening Mandated

Following Robert Guthrie's development of the bacterial inhibition assay for phenylketonuria, states in the U.S. began mandating newborn metabolic screening panels, eventually expanding to over 30 conditions.

2000 • NRP Guidelines Standardized

The American Academy of Pediatrics and American Heart Association published the Neonatal Resuscitation Program (NRP) algorithm, standardizing delivery room resuscitation based on evidence-based principles of airway, breathing, and circulation.

2010 • Pulse Oximetry Screening for CCHD

Critical congenital heart disease (CCHD) screening via pulse oximetry was added to the Recommended Uniform Screening Panel, catching ductal-dependent lesions before clinical deterioration.

The central question this lesson addresses is: how should a clinician systematically evaluate, stabilize, and provide preventive care for a newborn and infant across the first year of life? This includes the immediate delivery room assessment, neonatal resuscitation, routine screening, feeding guidance, immunization, and recognition of common pathologic conditions — all high-yield topics for USMLE Step 2.

SECTION 2

Core Principles of Newborn Assessment

Newborn care rests on a framework of rapid physiologic assessment, timely intervention, preventive screening, and anticipatory guidance. From the moment of delivery, the transition from fetal to neonatal circulation creates a critical window during which the clinician must evaluate respiratory effort, cardiac function, thermoregulation, and neuromuscular tone. The Apgar score serves as the initial standardized assessment, while subsequent examinations extend over the first hours, days, and months to identify congenital anomalies, metabolic disorders, and developmental delays.

Immediate Delivery Room Assessment

Evaluate the newborn's respiratory effort, heart rate, color, muscle tone, and reflex irritability using the Apgar score at 1 and 5 minutes. Initiate NRP steps if the infant is not vigorous.

Thermoregulation

Neonates lose heat rapidly via evaporation, convection, conduction, and radiation. Immediate drying, skin-to-skin contact, and radiant warmers prevent hypothermia, which increases oxygen consumption and metabolic acidosis.

Newborn Screening

Universal screening includes metabolic panels (PKU, galactosemia, congenital hypothyroidism), hearing assessment via otoacoustic emissions or ABR, and pulse oximetry for critical congenital heart disease.

Preventive Care & Immunization

Vitamin K injection prevents hemorrhagic disease of the newborn. Erythromycin eye prophylaxis prevents gonococcal ophthalmia neonatorum. Hepatitis B vaccine is administered within 24 hours of birth.

Feeding & Growth Monitoring

Exclusive breastfeeding is recommended for the first 6 months. Growth parameters (weight, length, head circumference) are plotted on WHO growth charts, with weight loss up to 7–10% in the first week considered physiologic.

✦

KEY TAKEAWAY

Think of newborn care like a pre-flight checklist for an aircraft: every system — respiratory, cardiovascular, metabolic, and thermoregulatory — must be verified in a systematic, time-sensitive sequence before the infant "clears the runway" of the fetal-to-neonatal transition. Missing a single checkpoint (e.g., skipping vitamin K or pulse oximetry) can result in a preventable catastrophic event hours or days later.

SECTION 3

Visual Explanation — Neonatal Resuscitation Algorithm

The NRP algorithm follows a stepwise escalation from initial assessment through positive pressure ventilation, chest compressions, and epinephrine administration. Heart rate (HR) is the primary decision point at each step. Note the target pre-ductal SpO₂ values by minute of life in the lower panel.

The NRP algorithm, depicted above, represents the cornerstone of delivery room management. Approximately 10% of newborns require some intervention to begin breathing, while only about 1% need extensive resuscitation. The algorithm is structured around sequential 30-second evaluation windows, with heart rate serving as the most critical indicator of response at each decision node. The transition from 21% oxygen (room air) to supplemental oxygen is guided by pre-ductal pulse oximetry placed on the right hand or wrist, with target saturations increasing incrementally over the first 10 minutes of life as fetal hemoglobin gradually achieves full oxygenation. An important update in recent NRP guidelines is the preference for cardiac monitoring (ECG leads) when chest compressions are initiated, as auscultation may be unreliable during compressions.

SECTION 4

The Apgar Score & Physiologic Mechanisms of Transition

The Apgar Score

The Apgar score assigns 0, 1, or 2 points to each of five parameters — Appearance (color), Pulse (heart rate), Grimace (reflex irritability), Activity (muscle tone), and Respiration (breathing effort) — yielding a total score of 0 to 10. A score of 7–10 at 1 minute is considered normal, 4–6 indicates moderate depression requiring intervention, and 0–3 signals severe depression necessitating aggressive resuscitation. The 5-minute Apgar is more predictive of long-term neurological outcome; a persistently low score (0–3) at 10 minutes is associated with increased mortality and morbidity.

Parameter	0 Points	1 Point	2 Points
Appearance	Blue/pale all over	Acrocyanosis (body pink, extremities blue)	Completely pink
Pulse	Absent	< 100 bpm	≥ 100 bpm
Grimace	No response to stimulation	Grimace/weak cry with stimulation	Cry, cough, sneeze with stimulation
Activity	Limp, no movement	Some flexion of extremities	Active motion, well-flexed
Respiration	Absent	Slow, irregular, weak cry	Good cry, regular breathing

Apgar Score Components — assessed at 1 and 5 minutes of life

Fetal-to-Neonatal Circulatory Transition

At birth, the first breath generates a large negative intrathoracic pressure that expands the lungs and dramatically decreases pulmonary vascular resistance (PVR). Simultaneously, clamping the umbilical cord removes the low-resistance placental circuit, increasing systemic vascular resistance (SVR). This reversal in the PVR/SVR ratio causes left atrial pressure to exceed right atrial pressure, functionally closing the foramen ovale. Increased arterial oxygen tension triggers constriction and eventual fibrosis of the ductus arteriosus, mediated by decreased prostaglandin E₂ and increased oxygen sensitivity. Failure of this transition — as seen in persistent pulmonary hypertension of the newborn (PPHN) — results in right-to-left shunting and severe hypoxemia refractory to supplemental oxygen alone.

⚠

HIGH-YIELD BOARD PEARL

Prostaglandin E₁ (alprostadil) is administered to maintain ductal patency in neonates with ductal-dependent congenital heart lesions (e.g., transposition of the great arteries, coarctation of the aorta). The primary side effect to remember is apnea, requiring intubation readiness.

SECTION 5

Newborn Screening, Immunization & Preventive Measures

Preventive care in the neonatal period encompasses universal screening programs, prophylactic medications, and timely immunizations. Each intervention targets a specific window of vulnerability, and understanding the rationale and timing is essential for both clinical practice and board examinations.

Timeline of preventive care interventions in the first 6 months of life. NBS = newborn screening; CCHD = critical congenital heart disease; DTaP = diphtheria-tetanus-acellular pertussis; IPV = inactivated polio vaccine; Hib = Haemophilus influenzae type b; PCV13 = pneumococcal conjugate vaccine; RV = rotavirus.

Key Prophylactic Interventions at Birth

✓ Vitamin K (phytonadione) 1 mg IM: Prevents hemorrhagic disease of the newborn (now termed vitamin K deficiency bleeding, VKDB). Neonates have sterile guts and limited hepatic stores, rendering them deficient in vitamin K-dependent clotting factors (II, VII, IX, X). Early VKDB occurs in the first 24 hours, classical at days 2–7, and late-onset at 2–12 weeks, often presenting as intracranial hemorrhage.
✓ Erythromycin 0.5% ophthalmic ointment: Applied bilaterally to prevent gonococcal ophthalmia neonatorum. Despite declining gonococcal incidence, this remains standard of care given the devastating risk of corneal perforation from untreated Neisseria gonorrhoeae infection.
✓ Hepatitis B vaccine (within 24 hours): Initiates the three-dose HepB series. For infants born to HBsAg-positive mothers, hepatitis B immune globulin (HBIG) is also administered within 12 hours of birth to prevent vertical transmission.

Newborn Metabolic Screening

The Recommended Uniform Screening Panel (RUSP) includes over 35 core conditions detectable through the heel-stick blood sample obtained between 24 and 48 hours of life. The timing is critical: collecting too early (before 24 hours) may miss phenylalanine elevation in PKU because the infant has not yet been feeding long enough to accumulate the metabolite, while delays beyond 48 hours risk irreversible neurologic damage from untreated metabolic disorders. Key conditions include congenital hypothyroidism (the most common preventable cause of intellectual disability), phenylketonuria, galactosemia, sickle cell disease, and congenital adrenal hyperplasia.

SECTION 6

Worked Clinical Example — Neonatal Jaundice Assessment

Neonatal jaundice is one of the most common reasons for readmission in the first week of life. The following worked example illustrates the clinical reasoning process for a jaundiced newborn, a classic USMLE Step 2 vignette.

Clinical Scenario: 3-Day-Old Jaundiced Newborn

1
Step 1 — Gather Clinical Data

A 3-day-old, 38-week gestation male infant born via vaginal delivery presents to the pediatrician's office for routine follow-up. The mother reports the baby appears yellow. Birth weight was 3.2 kg; current weight is 3.0 kg (6.3% weight loss). He is exclusively breastfeeding 8–10 times per day. Mother's blood type is O positive; baby's blood type is A positive. Direct Coombs test is positive.

Risk factors: ABO incompatibility (mother O, baby A), positive Coombs, breastfeeding
2
Step 2 — Assess Bilirubin Level in Context

Total serum bilirubin (TSB) is 15.2 mg/dL. Direct bilirubin is 0.4 mg/dL (unconjugated hyperbilirubinemia). Using the Bhutani nomogram for hour-specific bilirubin risk zones, at 72 hours of life a TSB of 15.2 mg/dL falls in the high-risk zone (>95th percentile). The infant also has a risk factor (hemolytic disease) that lowers the threshold for phototherapy.

TSB 15.2 mg/dL at 72 hrs → high-risk zone; hemolytic etiology confirmed
3
Step 3 — Determine Management

Per AAP guidelines, for a 38-week infant with risk factors, the phototherapy threshold at 72 hours is approximately 12–15 mg/dL. With TSB of 15.2 and a positive Coombs test indicating ongoing hemolysis, intensive phototherapy should be initiated immediately. The exchange transfusion threshold at this age with risk factors is approximately 20 mg/dL. A repeat TSB should be obtained in 4–6 hours to assess the rate of rise.

Management: Initiate intensive phototherapy; recheck TSB in 4–6 hours; continue breastfeeding
4
Step 4 — Identify Red Flags for Kernicterus

Monitor for signs of acute bilirubin encephalopathy: poor feeding, lethargy, high-pitched cry, hypertonia (retrocollis, opisthotonus), and seizures. These represent bilirubin-induced neurologic dysfunction (BIND) and constitute a medical emergency requiring immediate exchange transfusion regardless of TSB level. Chronic sequelae of kernicterus include choreoathetoid cerebral palsy, sensorineural hearing loss, and dental enamel dysplasia.

Any signs of bilirubin encephalopathy → emergency exchange transfusion

💡

CLINICAL PEARL

Physiologic jaundice peaks at days 3–5 in term infants and is never present in the first 24 hours of life. Jaundice appearing within the first 24 hours is always pathologic and most often due to hemolytic disease (ABO or Rh incompatibility, G6PD deficiency, spherocytosis). This distinction — physiologic vs. pathologic jaundice by timing of onset — is one of the most frequently tested concepts in neonatal care.

SECTION 7

Feeding, Growth Monitoring & Common Neonatal Conditions

Adequate nutrition in the first year of life is critical for neurodevelopment, immune maturation, and somatic growth. The clinician must be able to counsel families on feeding practices, recognize failure to thrive, and differentiate benign variations from pathologic conditions.

Topic	Key Facts	Board Pearls / Red Flags
Breastfeeding	Exclusive for 6 months per AAP/WHO. Provides IgA, lactoferrin, oligosaccharides. 8–12 feeds/day initially. Weight loss up to 7–10% in first week is normal.	Breastfeeding jaundice (insufficient intake, first week) vs. breast milk jaundice (UGT inhibition by β-glucuronidase, peaks week 2). Contraindicated with maternal HIV (in developed countries), active herpes on breast, or infant galactosemia.
Formula Feeding	Iron-fortified cow's milk-based formula standard. Soy-based for galactosemia. Hydrolyzed for cow's milk protein allergy.	No whole cow's milk before 12 months (risk of iron deficiency anemia, GI microhemorrhage). No honey before 12 months (infant botulism).
Weight Gain	Regain birth weight by day 10–14. Gain 20–30 g/day for first 3 months. Double birth weight by 4–5 months; triple by 12 months.	Weight loss >10% or failure to regain by 2 weeks warrants evaluation for feeding difficulties, pyloric stenosis, or metabolic disease.
Vitamin D Supplementation	400 IU/day for all breastfed infants starting shortly after birth, continued until weaned to ≥1 L/day of vitamin D-fortified formula or milk.	Deficiency leads to rickets: widened wrists, rachitic rosary, craniotabes, delayed fontanelle closure.
Iron Supplementation	Exclusively breastfed infants need 1 mg/kg/day of elemental iron starting at 4 months until iron-rich complementary foods are introduced.	Iron deficiency in infancy is the leading nutritional deficiency worldwide; associated with irreversible neurodevelopmental impairment.

Feeding and Nutritional Supplementation in Infancy

✦

FEEDING COUNSELING TAKEAWAY

A useful framework for growth velocity in the first year: an infant's weight approximately doubles by 5 months and triples by 12 months, while length increases by 50% and head circumference grows about 1 cm/month for the first year. Deviation from these trajectories — particularly head circumference crossing percentile lines — should prompt investigation for hydrocephalus (increasing) or microcephaly (decreasing).

SECTION 8

Connection to Advanced Neonatal & Pediatric Care

Routine newborn and infant care provides the foundation upon which complex neonatal medicine is built. Understanding normal physiology enables the clinician to recognize and manage the pathologic deviations that appear in advanced clinical scenarios — from the premature infant requiring surfactant therapy to the term neonate presenting with ambiguous genitalia suggestive of congenital adrenal hyperplasia.

Routine Newborn Care Concept	Advanced/Pathologic Extension
Apgar score assessment	Hypoxic-ischemic encephalopathy (HIE) — therapeutic hypothermia initiated within 6 hours for moderate-to-severe HIE (Sarnat staging)
Pulse oximetry CCHD screen	Ductal-dependent lesions (TGA, HLHS, coarctation) — PGE₁ infusion to maintain patency; definitive surgical repair
Surfactant-mediated lung compliance	Respiratory distress syndrome (RDS) — exogenous surfactant via INSURE technique; prenatal betamethasone for mothers at risk of preterm delivery
Metabolic newborn screen	Inborn errors of metabolism — tandem mass spectrometry identifies acylcarnitine and amino acid profiles; acute management of metabolic crises
Neonatal jaundice management	Biliary atresia (conjugated hyperbilirubinemia) — requires Kasai portoenterostomy before 60 days of life for optimal outcomes
Routine immunization schedule	Primary immunodeficiencies — absent thymic shadow, recurrent infections, contraindication to live vaccines (e.g., rotavirus in SCID)

From Routine Newborn Care to Advanced Neonatal Medicine

ℹ

LOOKING AHEAD

As you progress through pediatric clerkship and into residency, the principles of neonatal transition physiology, screening rationale, and preventive care will repeatedly surface in both clinical decision-making and board examinations. The distinction between conjugated vs. unconjugated hyperbilirubinemia exemplifies how a single laboratory value changes the entire differential and management pathway — unconjugated points toward hemolysis or physiologic jaundice, while conjugated (direct > 1 mg/dL or > 20% of total) demands urgent evaluation for biliary atresia, TORCH infections, or metabolic liver disease.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A healthy term newborn has mild acrocyanosis of the hands and feet at 3 minutes of life but is otherwise vigorous with good cry and flexed extremities. The mother is anxious and asks if the baby is "turning blue." Explain the physiologic basis of acrocyanosis in the newborn and whether this finding warrants intervention.

Show answer

Acrocyanosis — cyanosis limited to the extremities with a pink trunk — is a normal finding in the first 24–48 hours of life. It results from peripheral vasoconstriction as the newborn adapts to the extrauterine environment, where heat conservation is achieved partly by redirecting blood flow from the skin of the extremities to the core. This vasomotor instability is benign and self-limited. Central cyanosis (involving the trunk, mucous membranes, and lips), by contrast, indicates hypoxemia and requires immediate evaluation with pulse oximetry and possible supplemental oxygen. A vigorous infant with acrocyanosis alone would receive 1 point for color on the Apgar score and requires no intervention beyond reassurance and ongoing monitoring.

Question 2: BASIC CALCULATION

A newborn weighs 3.5 kg at birth. At the 5-day well-child visit, the infant weighs 3.22 kg. Calculate the percentage weight loss and determine whether this is within the physiologic range for a breastfed infant.

Show answer

Percentage weight loss = (birth weight − current weight) / birth weight × 100 = (3.5 − 3.22) / 3.5 × 100 = 0.28 / 3.5 × 100 = 8.0%. For breastfed infants, weight loss up to 7–10% in the first week is considered physiologic, attributed to loss of extracellular fluid and the time required for mature breast milk production (lactogenesis II typically occurs by day 3–5). An 8% loss at day 5 is within the acceptable range, though close to the upper limit. The infant should regain birth weight by day 10–14. If weight loss exceeds 10% or the infant has not regained birth weight by 2 weeks, evaluation for feeding adequacy, dehydration, or underlying pathology is warranted.

Question 3: INTERMEDIATE

A 36-hour-old infant born at 39 weeks to a blood type O-positive mother fails the critical congenital heart disease (CCHD) pulse oximetry screening with a pre-ductal SpO₂ of 93% and a post-ductal SpO₂ of 88%. What is the differential diagnosis, and what are the immediate next steps in management?

Show answer

The CCHD screen is considered failed when SpO₂ is < 90% in either extremity, or < 95% in both extremities on three separate measurements an hour apart, or when there is a > 3% difference between pre-ductal and post-ductal readings. This infant fails on multiple criteria: post-ductal SpO₂ < 90% and a pre-to-post-ductal difference of 5%. The differential includes ductal-dependent cyanotic congenital heart diseases such as coarctation of the aorta, interrupted aortic arch, critical aortic stenosis, and transposition of the great arteries. Non-cardiac causes such as persistent pulmonary hypertension (PPHN) or pneumonia should also be considered. Immediate management includes obtaining a four-extremity blood pressure, chest radiograph, arterial blood gas, and an echocardiogram. A prostaglandin E₁ infusion (0.05–0.1 μg/kg/min) should be started if a ductal-dependent lesion is suspected, with the understanding that the major side effect is apnea requiring intubation readiness. Pediatric cardiology should be consulted emergently.

Question 4: APPLIED

A 2-week-old infant presents with progressive jaundice, acholic (pale) stools, dark urine, and hepatomegaly. Total bilirubin is 9.8 mg/dL with a direct fraction of 5.2 mg/dL. The parents initially assumed this was "normal newborn jaundice." Explain why this presentation is concerning, the most likely diagnosis, and the time-sensitive management required.

Show answer

This infant has conjugated (direct) hyperbilirubinemia, defined as direct bilirubin > 1 mg/dL or > 20% of total bilirubin. Unlike physiologic unconjugated jaundice, conjugated hyperbilirubinemia is always pathologic and indicates impaired bile excretion. The combination of acholic stools (indicating absence of bilirubin in the gut), dark urine (conjugated bilirubin is water-soluble and renally excreted), and hepatomegaly strongly suggests biliary atresia, a progressive fibroinflammatory obliteration of the extrahepatic bile ducts. The key diagnostic studies include a hepatobiliary iminodiacetic acid (HIDA) scan (which will show hepatic uptake but no excretion into the intestine) and ultimately an intraoperative cholangiogram. The Kasai portoenterostomy (hepatoportoenterostomy) must be performed before 60 days of life — and ideally before 30 days — for optimal outcomes, as delay leads to irreversible biliary cirrhosis requiring liver transplantation. This case underscores the critical teaching point that any infant with jaundice persisting beyond 2 weeks requires a fractionated bilirubin to rule out cholestatic liver disease.

Question 5: CRITICAL THINKING

A term infant born via uncomplicated vaginal delivery is noted to have a heart rate of 40 bpm at 1 minute of life despite vigorous stimulation, drying, and clearing of the airway. The infant is apneic and cyanotic. Positive pressure ventilation is initiated with room air at 40–60 breaths/min for 30 seconds, but the heart rate remains at 45 bpm. Walk through the complete NRP algorithm for this infant, including all subsequent steps, medication dosing, and decision points. Discuss what underlying condition should be considered if the infant fails to respond to standard resuscitation.

Show answer

This infant presents with severe bradycardia (< 60 bpm) and apnea, warranting immediate escalation through the NRP algorithm. Step A (initial steps) has been completed: warm, dry, stimulate, clear airway. Step B (PPV) has been attempted for 30 seconds without adequate response. Before escalating, the clinician should verify effective ventilation: ensure proper mask seal, reposition the head in the "sniffing" position, suction if needed, open the mouth, and increase pressure (the MR SOPA corrective steps). If the heart rate remains < 60 bpm after 30 seconds of effective PPV, proceed to intubation and Step C: coordinated chest compressions with PPV at a 3:1 ratio (90 compressions and 30 ventilations per minute = 120 events/min). Compressions are delivered using the two-thumb encircling technique at the lower third of the sternum, depressing one-third of the anteroposterior chest diameter. Increase FiO₂ to 100% during compressions. After 60 seconds of coordinated compressions and ventilation, if HR remains < 60 bpm, proceed to Step D: administer epinephrine. The preferred route is IV via umbilical venous catheter at 0.01–0.03 mg/kg (0.1–0.3 mL/kg of 1:10,000 concentration). If IV access is not yet available, endotracheal epinephrine may be given at a higher dose: 0.05–0.1 mg/kg (0.5–1 mL/kg of 1:10,000). Consider volume expansion with 10 mL/kg of normal saline if there is suspected blood loss. If the infant fails to respond to all resuscitation measures, the differential must include congenital complete heart block (associated with maternal anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus), severe congenital heart disease, severe sepsis, pneumothorax, or congenital diaphragmatic hernia. An echocardiogram and chest radiograph should be obtained urgently once the infant is stabilized.

SUMMARY

Newborn and Infant Care — Comprehensive Review

Summary

Newborn and infant care encompasses a systematic approach beginning with the Apgar score at 1 and 5 minutes, followed by the NRP resuscitation algorithm when intervention is needed. Key prophylactic measures at birth include vitamin K injection to prevent VKDB, erythromycin eye prophylaxis against gonococcal ophthalmia, and hepatitis B vaccination within 24 hours. Universal newborn screening at 24–48 hours detects over 35 treatable conditions, while pulse oximetry CCHD screening catches ductal-dependent cardiac lesions before clinical deterioration.

Longitudinal infant care centers on exclusive breastfeeding for 6 months with vitamin D (400 IU/day) and iron supplementation at 4 months, growth monitoring using WHO charts (birth weight doubles by 5 months, triples by 12 months), and adherence to the immunization schedule beginning at 2 months with DTaP, IPV, Hib, PCV13, and rotavirus. Critical distinctions for board examinations include physiologic vs. pathologic jaundice (timing of onset and conjugated vs. unconjugated bilirubin), the significance of conjugated hyperbilirubinemia as always pathologic (biliary atresia requires Kasai before 60 days), and the use of prostaglandin E₁ for ductal-dependent congenital heart disease.